Castleark Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Castleark Management's HALO Position: Q4 2024 in Review
Castleark Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 69,720 shares — an estimated $3.99M sold.
Castleark Management first reported a position in HALO in Q3 2017 and held it in 17 quarters. The position peaked at $21.3M in Q4 2020. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.
- Castleark Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
- Castleark Management sold 69,720 Halozyme shares in Q4 2024, an estimated $3.99M.
- Castleark Management first reported a position in Halozyme in Q3 2017 and held it in 17 quarters.
- Castleark Management's Halozyme position peaked at $21.3M in Q4 2020.
- 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.
Based on Castleark Management's 13F filing for Q4 2024, filed 18 Feb 2025.